China API Juggernaut Rolls On But Can India Recoup?

Report: India’s huge dependence on Chinese active pharmaceutical ingredients (APIs), including in high disease burden areas, poses heightened risks to its health security and requires “urgent interventions.”

Pills — INDIA'S HIGH DEPENDENCE ON CHINA FOR APIs IS A CAUSE FOR WORRY

India could be staring at a national health crisis in the backdrop of its continuing massive reliance on Chinese active pharmaceutical ingredients (APIs), including those used in drugs for high-burden diseases such as diabetes and cardiovascular ailments, according to a report by the professional services firm KPMG and the Confederation of Indian Industry (CII).

India accounts for 20% of the global disease burden and in addition to communicable diseases such as malaria and tuberculosis,...